Note to our followers: Our nearly 13-year run of daily publication of new content on came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tags: breast cancer


A little more context would have boosted already-strong HealthDay story on drug for hot flashes


Litany of errors hampers Reuters story on experimental breast cancer drug


Talazoparib touted as ‘promising,’ but is it any better than a similar breast cancer drug that’s already available?


Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier


In story on texting program for chemo patients, Reuters Health keeps most study details on the DL


A study that may help reduce overtreatment of breast cancer gets solid write-up by Bloomberg


Independent viewpoint helps round out HealthDay story on impact of earlier mammograms

1 3/8/2018

USA Today rehashes PR talking points in story on at-home breast cancer gene test


‘It’s unknown whether treatment increases survival,’ AP wisely notes about new breast cancer drug

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery